Vista Pharma Not Classified as a Large Corporate, Exempt From Debt Fundraising Rules
Vista Pharmaceuticals Ltd 路 Others (Uncategorized) 路 29 Apr 2026, 5:30 pm
Vista Pharma Not Classified as a Large Corporate, Exempt From Debt Fundraising Rules Vista Pharmaceuticals Ltd (BSE: 524711) announced on 29 Apr'26 that it does not fall under the Large Corporate (LC) category as per SEBI's framework. Consequently, the company is not subject to the mandatory requirement of raising a portion of its incremental borrowings through the issuance of debt securities. The disclosure for FY26 confirms no mandatory borrowing was required and no actual borrowing was done via debt securities, indicating no shortfall or applicable penalties for the reported period.
Original exchange filing (PDF)
More announcements from Vista Pharmaceuticals Ltd
- Resignation of Company Secretary & Compliance Officer 路 12 Sept 2026
- Results for the quarter ended 30.06.2026 路 14 Aug 2026
- Results for the quarter ended 30.06.2026 路 14 Aug 2026
- Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. Unaudited financial .... 路 14 Aug 2026
- Board meeting outcome 路 29 May 2026
- Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. Audited financial .... 路 29 May 2026
- Un audited Financial Results for the quarter ended 31.12.2025 路 13 Feb 2026
- Results for the quarter ended 31.12.2025 路 13 Feb 2026
